Particle.news

Download on the App Store

Paclitaxel Disrupts Brain’s Master Clock in Female Mice, eNeuro Study Finds

The findings prompt tests of whether reinforcing clear day–night cues reduces chemotherapy side effects.

Overview

  • Ohio State University researchers report that paclitaxel altered circadian function in the suprachiasmatic nucleus, according to an eNeuro paper published in September 2025.
  • Chemotherapy-treated mice showed abnormal daily patterns of circadian gene expression in the brain’s pacemaker region.
  • Treated animals adapted poorly to light-based challenges, indicating disrupted behavioral rhythms tied to the clock.
  • The experiment used only female mice due to breast cancer relevance, highlighting preclinical scope and the need for human confirmation.
  • Results underscore a paradox of clock disruption despite limited brain penetration by many chemotherapies, pointing to possible indirect mechanisms and low-risk behavioral interventions to evaluate.